The FDA approved the Biotronik portfolio of Amvia Edge pacemakers last month. Dr. Raul Weiss completed the procedure at Mount Sinai Medical Center in Miami, Florida.
“I was very pleased to have been a part of the first implant of Amvia Edge. The procedure went well, and I’m excited about the benefits this new device will be able to bring to our patients as well as our practice,” said Weiss. “The ability to eliminate device scans before and after an MRI procedure is a much-needed advancement, and I look forward to seeing how these types of technologies help streamline our workflows in the future.”
More about the Biotronik Amvia Edge pacemaker family
Lake Oswego, Oregon-based Biotronik designed Amvia Edge as the market’s smallest single-chamber MR conditional pacemaker. It offers a set of patient-centric solutions coupled with automated workflow efficiency. Amvia Edge features MRI Guard 24/7, the market’s only dedicated, always-on MRI sensor.
MRI Guard 24/7 allows a clinic to substantially reduce the time of burden of device management for MRI scans. It automatically recognizes when the patient enters an MRI field, then converts the device to MRI mode. Amvia Edge then automatically returns to its permanent programming following the scan’s completion. According to Biotronik, this eliminates any pre- or post-scan programming needs.
Biotronik also made Amvia Edge its first pacemaker family to offer EarlyCheck, a workflow simplification tool that automates pre-discharge checks. It automatically delivers a device report and IEGM to the Biotronik Home Monitoring Service Center two hours post-implant. This eliminates the need for an in-person device interrogation.
Amvia Edge also offers Atrial ATP (aATP), which provides multiple, automatic therapies in response to detected stable atrial arrhythmias. Biotrink said this may reduce atrial tachycardia burden and help avoid atrial remodeling.
“I’m so pleased to hear about Dr. Weiss and his team’s successful first implant of Amvia Edge,” said Dr. David Hayes, chief medical officer, Biotronik. “This new family of devices was designed to optimize workflows and therapies to benefit patients and their care teams, as well as clinicians and staff.”
